{"id":1271,"date":"2023-08-26T07:25:43","date_gmt":"2023-08-26T07:25:43","guid":{"rendered":"https:\/\/www.breastaware.gr\/?page_id=1271"},"modified":"2025-08-10T12:15:29","modified_gmt":"2025-08-10T12:15:29","slug":"%cf%80%cf%81%ce%bf%cf%87%cf%89%cf%81%ce%b7%ce%bc%ce%ad%ce%bd%ce%b7-%ce%b7%ce%bb%ce%b9%ce%ba%ce%af%ce%b1","status":"publish","type":"page","link":"https:\/\/www.breastaware.gr\/en\/%ce%ba%ce%b1%cf%81%ce%ba%ce%af%ce%bd%ce%bf%cf%82-%ce%bc%ce%b1%cf%83%cf%84%ce%bf%cf%8d\/%cf%80%cf%81%ce%bf%cf%87%cf%89%cf%81%ce%b7%ce%bc%ce%ad%ce%bd%ce%b7-%ce%b7%ce%bb%ce%b9%ce%ba%ce%af%ce%b1\/","title":{"rendered":"Advanced Age"},"content":{"rendered":"
\n
\n\t

\"\"<\/p>\n

Breast Cancer in Older Women: What You Should Know<\/strong><\/p>\n

Breast cancer in elderly women presents a significant challenge for modern healthcare. The average age at diagnosis is around 62 years, with 25% of cases occurring in women aged 75-84. Projections indicate that by 2030, breast cancer cases will double, with most new diagnoses in women aged 70-84.<\/p>\n

 <\/p>\n

Why Age Alone Isn\u2019t Enough<\/strong><\/p>\n

Despite the increasing incidence, there are no clear international guidelines specifically for managing breast cancer in older women. This is largely because older age groups are often excluded from clinical trials, limiting data on treatment efficacy and safety.<\/p>\n

Age alone should not determine<\/strong> treatment decisions. The patient's overall health, comorbidities (e.g., hypertension, diabetes, cardiorespiratory diseases), as well as tumor characteristics (e.g., hormone receptors, extent, aggressiveness) and the patient's personal wishes are equally critical.<\/p>\n

 <\/p>\n

Balancing Under- and Overtreatment<\/strong><\/p>\n

In older ages, application is often observed less aggressive treatment,<\/strong> which may negatively affect the prognosis. On the other hand, the overtreatment<\/strong> \u2013 that is, the use of intense therapeutic interventions without absolute indication \u2013 can cause serious side effects without substantial benefit, especially when the likelihood of disease recurrence is lower than the threat posed by other health problems.<\/p>\n

The personalization of treatment<\/strong> is the key to safe and effective treatment of breast cancer in older women.<\/p>\n

 <\/p>\n

Diagnosis: The Role of Biopsy<\/strong><\/p>\n

Biopsy under local anesthesia remains essential for treatment planning, providing critical information on:<\/p>\n